Relative contribution of nonstructural protein 1 in dengue pathogenesis

Area of Science:

• Virology
• Immunology
• Public Health

Background:

• Dengue is a significant global health issue with no effective treatments.
• Subunit vaccine development is ongoing, with nonstructural protein 1 (NS1) as a focus.
• Previous research suggests NS1 may be a promising dengue vaccine target.

Purpose of the Study:

• To evaluate the efficacy of NS1-based immunization and antibody transfer in dengue mouse models.
• To investigate the role of NS1 in dengue virus virulence and pathogenesis.
• To assess the potential of NS1 as a universal dengue vaccine candidate.

Main Methods:

• Utilized symptomatic dengue mouse models with two virulent, non-mouse-adapted DENV2 strains.
• Administered NS1 immunization and passive transfer of NS1 antibodies.
• Tested exogenous purified NS1 for its effect on vascular leakage.
• Created chimeric dengue virus strains involving the prME structural region.
• Analyzed the induction of proinflammatory cytokines.

Main Results:

• NS1 immunization and antibody transfer failed to protect against severe dengue.
• Exogenous NS1 did not exacerbate in vivo vascular leakage.
• Immune neutralization of NS1 did not alter disease outcomes in chimeric strains.
• Virus chimerization involving the prME structural region demonstrated its critical role in virulence.
• prME proteins induced key proinflammatory cytokines, driving viral fitness and pathogenicity.

Conclusions:

• The pathogenic role of NS1 in dengue is strain-dependent.
• NS1 is not a universally protective antigen and may not be a suitable universal dengue vaccine candidate.
• Dengue virus structural proteins (prME) are critical drivers of in vivo virulence and pathogenesis.